List of insiders holdings for Kala Pharmaceuticals, Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Grunberg Gregory Director | 2021-06-21 17:30:18 | 40,000 5,411,860 | 5,451,860 | Form 4 |
| RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 2022-06-03 17:11:23 | 3,412,868 0 | 3,412,868 | Form 13D |
| TEPPER ROBERT I Director | 2017-07-26 16:30:49 | 0 1,654,425 | 1,654,425 | Form 4 |
| Lux Capital Management LLC Lux Venture Associates II LLC Lux Venture Partners II L.P. Lux Ventures II Sidecar LP Lux Ventures II L.P. 10% Owner | 2017-07-19 17:35:34 | 0 1,289,067 | 1,289,067 | Form 3 |
| CVF LLC 10% Owner | 2017-07-19 17:23:39 | 1,190,787 0 | 1,190,787 | Form 3 |
| CDK ASSOCIATES L.L.C. CAXTON CORP Kovner Bruce 10% Owner | 2017-07-21 17:54:22 | 763,755 0 | 763,755 | Form 4/A |
| Ysios BioFund I FCR 10% Owner | 2017-07-19 17:32:11 | 729,391 0 | 729,391 | Form 3 |
| Hanes Justin 10% Owner | 2017-07-19 18:14:16 | 601,923 0 | 601,923 | Form 3 |
| Polaris Venture Management Co. V L.L.C. Polaris Venture Partners Entrepreneurs' Fund V L.P. Polaris Venture Partners Founders' Fund V L.P. Polaris Venture Partners Special Founders' Fund V L.P. Polaris Venture Partners V L.P. 10% Owner | 2020-02-12 16:55:02 | 598,620 0 | 598,620 | Form 13G |
| Chen Hongming CHIEF SCIENTIFIC OFFICER | 2021-10-28 20:06:52 | 204,515 0 | 204,515 | Form 4 |
| Longitude Capital Partners II LLC ENRIGHT PATRICK G Tammenoms Bakker Juliet Longitude Venture Partners II L.P. 10% Owner | 2023-02-14 16:15:16 | 108,239 0 | 108,239 | Form 13D |
| McDermott Charles Douglas President and Chief Bus. Off. 10% Owner | 2017-07-21 16:07:52 | 86,056 0 | 86,056 | Form 3/A |
| KOVEN ANDREW I Director | 2022-06-17 16:45:19 | 50,000 0 | 50,000 | Form 4 |
| Paull Robert Bradley Director | 2022-06-17 16:45:28 | 40,000 0 | 40,000 | Form 4 |
| Myers C. Daniel Director | 2022-06-17 16:46:01 | 40,000 0 | 40,000 | Form 4 |
| Blumenkranz Mark S. Director | 2022-06-17 16:45:46 | 40,000 0 | 40,000 | Form 4 |
| Rosen Howard B Director | 2022-06-17 16:45:55 | 40,000 0 | 40,000 | Form 4 |
| PERRY GREGORY D Director | 2022-06-17 16:45:38 | 40,000 0 | 40,000 | Form 4 |
| LANGER ROBERT Director | 2018-06-15 10:50:56 | 12,960 0 | 12,960 | Form 4 |
| Hill Paulina Director | 2018-06-14 16:47:13 | 12,960 0 | 12,960 | Form 4 |
| LaRussa Michele Sr. VP, Regulatory and Quality | 2018-02-09 16:29:59 | 8000 0 | 8000 | Form 4 |
| Farid Marjan Director | 2022-11-01 16:12:36 | 1600 0 | 1600 | Form 4 |
| Iwicki Mark T CHIEF EXECUTIVE OFFICER | 2023-03-15 20:00:10 | 1512 0 | 1512 | Form 4 |
| Bazemore Todd SEE REMARKS | 2023-03-15 20:00:13 | 576 0 | 576 | Form 4 |
| Brazzell Romulus K SEE REMARKS | 2023-03-15 20:00:15 | 576 0 | 576 | Form 4 |
| Reumuth Mary CHIEF FINANCIAL OFFICER | 2023-03-15 20:00:18 | 432 0 | 432 | Form 4 |
| Trachtenberg Eric SEE REMARKS | 2023-03-15 20:00:22 | 432 0 | 432 | Form 4 |
| Kharabi Darius CHIEF BUSINESS OFFICER | 2023-03-15 20:00:23 | 432 0 | 432 | Form 4 |
| Hadley Harbor Master Investors (Cayman) L.P. 10% Owner | 2019-02-12 10:16:16 | 0 0 | 0 | Form 13G |
| ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ISALY SAMUEL D 10% Owner | 2021-10-14 17:00:52 | 0 0 | 0 | Form 13G |
| ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 2021-10-14 17:00:52 | 0 0 | 0 | Form 13G |